Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-22,646
Closed -$2.33M 392
2017
Q3
$2.33M Sell
22,646
-2
-0% -$197 0.04% 267
2017
Q2
$2.12M Buy
22,648
+309
+1% +$26.1K 0.03% 269
2017
Q1
$1.81M Sell
22,339
-192
-0.9% -$16.1K 0.03% 270
2016
Q4
$1.97M Buy
+22,531
New +$1.91M 0.03% 265

Other funds holding ANDV

Boston Trust Walden's ANDV Position: Q4 2017 in Review

Boston Trust Walden sold out of Andeavor (ANDV) in Q4 2017, closing a stake of 22,646 shares — an estimated $2.33M sold.

Boston Trust Walden first reported a position in ANDV in Q4 2016 and held it in 4 quarters. The position peaked at $2.33M in Q3 2017. 633 funds tracked by Wall St. Rank hold ANDV as of Q4 2017.

  • Boston Trust Walden reported no remaining Andeavor position as of Q4 2017 after selling out during the quarter.
  • Boston Trust Walden sold 22,646 Andeavor shares in Q4 2017, an estimated $2.33M.
  • Boston Trust Walden first reported a position in Andeavor in Q4 2016 and held it in 4 quarters.
  • Boston Trust Walden's Andeavor position peaked at $2.33M in Q3 2017.
  • 633 funds tracked by Wall St. Rank held Andeavor as of Q4 2017.

Based on Boston Trust Walden's 13F filing for Q4 2017, filed 29 Jan 2018.